Trials / Completed
CompletedNCT00165282
Mindfulness Meditation in Bone Marrow Transplantation
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 241 (actual)
- Sponsor
- Emory University · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to examine techniques to help patients cope better with the stem cell/bone marrow transplant procedure.
Detailed description
Patients will be assigned to one of three study groups: 1. receives the normal standard care; 2. meets with an oncology nurse educator, in addition to the regular nurses on the transplant team. The nurse educator will provide information and answers to patient's questions about the stem cell/bone marrow transplant experience; or 3. is taught mindfulness meditation by a nurse who is trained to be a mindfulness instructor and by an audio CD. Mindfulness meditation is a technique that may help in coping with the stress and difficulties associated with cancer and undergoing a stem cell/bone marrow transplant. It involves learning to be in the present moment by paying attention to your breathing, sights, and sounds, and to sensations you may be experiencing, or thoughts and feelings you may be having. Mindfulness meditation has been shown to be helpful to patients in the clinic who have cancer and other medical conditions. Patients, regardless of random group assignment, will complete a questionnaire 8 different times, from before they are admitted to the hospital until 6 months after discharge. Patients will also provide two urine samples while in the hospital to measure the levels of stress hormones present in the urine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mindfulness training | Taught mindfulness meditation by mindfulness instructor (trained health care professional/RN) and audio c/d |
| BEHAVIORAL | Nurse education | Meets with oncology nurse to have questions answered about medical treatments and side effects |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2010-01-01
- Completion
- 2011-06-01
- First posted
- 2005-09-14
- Last updated
- 2013-11-28
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00165282. Inclusion in this directory is not an endorsement.